Posters

Surgical treatment of submacular haemorrhage with tissue plasminogen activator

Poster Details

First Author: T.Stavropoulou GREECE

Co Author(s):    D. Pagoulatos   P. Dimitrakas   P. Petrou   I. Georgalas                    

Abstract Details



Purpose:

To assess the efficacy of intravitreal injection of OCT-Afluoropropane (C3F8) gas in combination with tissue plasminogen activator (tPA) for displacing submacular haemorrhage.

Setting:

Α University clinic of ophthalmology, GNA Gennimatas

Methods:

20 cases of submacular haemorrhage were treated with 23G pars plana vitrectomy,subretinal injection of tPA and C3F8 gas intravitrealy. Submacular haemorrhage was related to exudative age-related macular degeneration (AMD) in 12 eyes and ruptured retinal arterial macroaneurysms in 8 eyes.

Results:

Compared with the preoperative VA (follow-up of 12 months), the final visual acuity (VA) improved by 3/10 in 12 eyes (60%), stabilized in 4 eyes (20%), and deteriorated in 4 eyes (20%). In eyes with AMD, haemorrhage including vitreous haemorrhage recurred in 3 (25%) of 12 eyes treated . In eyes with macroaneurysms, haemorrhage recurred in 2 cases (25%).2 eyes underwent vitrectomy for recurrent haemorrhage. During follow-up, intravitreal ranibizumab was administered in 5 (41.6%) of 12 eyes with AMD. No other complications were observed.

Conclusions:

Intravitreal C3F8 gas plus tPA provide good visual outcomes and no remarkable complications for treating submacular haemorrhage.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy